Your browser doesn't support javascript.
loading
TCGA molecular classification in endometriosis-associated ovarian carcinomas: Novel data on clear cell carcinoma.
Similä-Maarala, Jonna; Soovares, Piret; Pasanen, Annukka; Ahvenainen, Terhi; Vahteristo, Pia; Bützow, Ralf; Lassus, Heini.
Affiliation
  • Similä-Maarala J; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Haartmaninkatu 3, PO Box 400, 00290 HUS, Helsinki, Finland. Electronic address: jonna.simila-maarala@hus.fi.
  • Soovares P; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 2, PO Box 140, 00029 HUS, Helsinki, Finland. Electronic address: piret.soovares@hus.fi.
  • Pasanen A; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Haartmaninkatu 3, PO Box 400, 00290 HUS, Helsinki, Finland. Electronic address: annukka.pasanen@hus.fi.
  • Ahvenainen T; Department of Medical and Clinical Genetics and Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland, University of Helsinki, Haartmaninkatu 8, PO Box 63, 00014, Finland. Electronic address: terhi.ahven
  • Vahteristo P; Department of Medical and Clinical Genetics and Applied Tumor Genomics Research Program, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland, University of Helsinki, Haartmaninkatu 8, PO Box 63, 00014, Finland. Electronic address: pia.vahteri
  • Bützow R; Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, Haartmaninkatu 3, PO Box 400, 00290 HUS, Helsinki, Finland. Electronic address: ralf.butzow@hus.fi.
  • Lassus H; Department of Obstetrics and Gynecology, Gynecologic Oncology, University of Helsinki and Helsinki University Hospital, Haartmaninkatu 2, PO Box 140, 00029 HUS, Helsinki, Finland. Electronic address: heini.lassus@hus.fi.
Gynecol Oncol ; 165(3): 577-584, 2022 06.
Article de En | MEDLINE | ID: mdl-35370008
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs de l'endomètre / Carcinome endométrioïde / Adénocarcinome à cellules claires / Endométriose Type d'étude: Risk_factors_studies Limites: Female / Humans Langue: En Journal: Gynecol Oncol Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire / Tumeurs de l'endomètre / Carcinome endométrioïde / Adénocarcinome à cellules claires / Endométriose Type d'étude: Risk_factors_studies Limites: Female / Humans Langue: En Journal: Gynecol Oncol Année: 2022 Type de document: Article Pays de publication: États-Unis d'Amérique